[1]马倩茹,唐 磊,郝秀芳,等.名中医王国华从“虚、毒、瘀”辨治高危型人乳头瘤病毒感染经验[J].陕西中医,2025,46(1):109-113.[doi:DOI:10.3969/j.issn.1000-7369.2025.01.024]
 MA Qianru,TANG Lei,HAO Xiufang,et al.WANG Guohua's experience in treating high-risk human papillomavirus infection from “deficiency,poison and stasis”[J].,2025,46(1):109-113.[doi:DOI:10.3969/j.issn.1000-7369.2025.01.024]
点击复制

名中医王国华从“虚、毒、瘀”辨治高危型人乳头瘤病毒感染经验
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
46
期数:
2025年1期
页码:
109-113
栏目:
名中医经验
出版日期:
2025-01-05

文章信息/Info

Title:
WANG Guohua's experience in treating high-risk human papillomavirus infection from “deficiency,poison and stasis”
作者:
马倩茹1唐 磊1郝秀芳2王国华2
(1.北京中医药大学第三临床医学院,北京 100029; 2.北京中医药大学第三附属医院妇科,北京 100029)
Author(s):
MA QianruTANG LeiHAO XiufangWANG Guohua
(The Third Clinical College of Beijing University of Chinese Medicine,Beijing 100029,China)
关键词:
高危型人乳头瘤病毒感染 虚实错杂 病机 益气解毒化瘀汤 对药 形神同调
Keywords:
High-risk human papillomavirus infection Deficiency and reality are mixed Pathogenesis Yiqi Jiedu Huayu decoction Match the medicine Homology in form and spirit
分类号:
R 249
DOI:
DOI:10.3969/j.issn.1000-7369.2025.01.024
文献标志码:
A
摘要:
高危型人乳头瘤病毒(HR-HPV)持续感染可造成癌前病变、宫颈癌、宫颈上皮内瘤变等疾病,是目前妇科常见疾病之一。西医治疗HR-HPV感染效果有一定局限性。王国华教授临证发现HR-HPV感染多与“虚、毒、瘀”互结有关,认为虚实错杂是其病机本质。紧扣“虚”为HR-HPV感染之发病基础,“毒”为HR-HPV感染之致病关键,“瘀”为HR-HPV感染之病情转枢,认为“虚、瘀、毒”贯穿HR-HPV感染发病始终,自拟益气解毒化瘀汤加减以扶正祛邪,巧用经验对药,灵活加减,治疗同时注重形神同调,身心合治,疗效显著。
Abstract:
HighCrisk human papillomavirus(HR-HPV)continuous infection can cause precancerous lesions,cervical cancer,cervical intraepithelial neoplasia and other diseases,is one of the common gynecological diseases.The effect of Western medicine on HR-HPV infection has certain limitations.Professor WANG Guohua found that HR-HPV infection was mostly related to “deficiency,toxin and stasis”,and believed that the pathogenesis of HR-HPV was complicated with deficiency and accumulation.“Deficiency” is the basis of HR-HPV infection,“poison” is the key to the pathogenesis of HR-HPV infection,and “blood stasis” is the turning point of HR-HPV infection.It is believed that “deficiency,stasis and poison” run through the onset of HR-HPV infection.Yiqi Jiedu Huayu decoction should be added or decreased to fuzheng and dispelling evil,and the treatment should pay attention to the coherence of form and spirit at the same time.The combined treatment of body and mind has remarkable curative effect.

参考文献/References:

[1] 曹泰华,刘双爱,赵祖国.宫颈病变患者血清白细胞介素2、白细胞介素4、干扰素γ水平与高危型HPV感染相关性研究[J].陕西医学杂志,2023,52(11):1546-1549,1553.
[2] LI Y,LIU X,HAN C,et al.Prevalence and genotype distribution of high-risk human papillomavirus in 34420 cases in Yangzhou city,Jiangsu province,China[J].J Med Virol,2021,93(8):5095-5102.
[3] TOTTEN S,ROMERO J M.High-risk human papillomavirus testing for cervical cancer screening[J].JAMA Oncol,2021,7(7):1066-1067.
[4] YAMAZAKI H,WADA T,ASANO H,et al.Comparison between urine and cervical high-risk HPV tests for Japanese women with ASC-US[J].Diagnostics(Basel),2021,11(10):1895.
[5] 米兰,毕蕙.人乳头瘤病毒所致感染的防控[J].中国实用妇科与产科杂志,2024,40(7):687-692.
[6] 钱海墨,方晓红,王思慧,等.何氏女科对妇女高危型人乳头瘤病毒感染的认识与中医治疗[J].中华中医药杂志,2023,38(12):5851-5854.
[7] 刘婕,徐力.徐力运用“截断疗法”治疗宫颈人乳头瘤病毒感染经验撷菁[J].陕西中医,2021,42(1):106-108.
[8] 陈苇,杨正望,夏雨,等.沈金鳌治疗带下病学术思想及用药特点探析[J].陕西中医,2020,41(9):1315-1319.
[9] 王秀青,夏敏,陈蓉,等.中医药治疗宫颈高危型人乳头瘤病毒感染的临床研究进展[J].世界科学技术-中医药现代化,2022,24(7):2557-2561.
[10] 曹珊,张艺嘉,樊珂.崔应民治疗持续性HPV感染临床经验撷英[J].时珍国医国药,2021,32(4):981-984.
[11] 余娇,代琼花,李彦链,等.秦竹基于“一体两翼”学术思想论治HPV感染[J].中医学报,2024,39(8):1733-1738.
[12] 王嫱,郭洁,宋殿荣,等.宫颈高危型人乳头瘤病毒感染的中医证候特征研究[J].广州中医药大学学报,2024,41(7):1669-1675.
[13] 缪雨希,曾根平,黎佩银,等.基于“湿热蕴毒”探讨宫颈高危型人乳头瘤病毒感染“炎-癌转化”的中医药干预思路[J].广州中医药大学学报,2024,41(9):2472-2478.
[14] 林雪儿,梁怀枫,李道成.基于数据挖掘探析高危型人乳头瘤病毒感染的中药复方组方规律[J].湖南中医药大学学报,2024,44(1):86-92.
[15] 于明玥,杨婕,张丽娟.刘瑞芬教授基于“内外合邪”治疗HPV感染经验浅析[J].时珍国医国药,2023,34(4):970-971.
[16] REN X,CHEN H,WANG H,et al.Advances in the pharmacological effects and mechanisms of nelumbo nucifera gaertn extract nuciferine[J].J Ethnopharmacol,2024,331:118262.
[17] JIA J,CHEN J,WANG G,et al.Progress of research into the pharmacological effect and clinical application of the traditional Chinese medicine rehmanniae radix[J].Biomed Pharmacother,2023,168:115809.
[18] RAFIQ S,HAO H,IJAZ M,et al.Pharmacological Effects of houttuynia cordata thunb(H.cordata):A comprehensive review[J].Pharmaceuticals(Basel),2022,15(9):1079.
[19] SRICHAIYO N,TONGSIRI S,HOSEINIFAR S H,et al.The effect of fishwort(Houttuynia cordata)on skin mucosal,serum immunities,and growth performance of Nile tilapia[J].Fish Shellfish Immunol,2020,98:193-200.
[20] CHEN C,XIE X,LI X.Immunomodulatory effects of four polysaccharides purified from erythronium sibiricum bulb on macrophages[J].Glycoconj J,2021,38(4):517-525.
[21] ZHANG R,MA C,WEI Y,et al.Isolation,purification,structural characteristics,pharmacological activities,and combined action of hedyotis diffusa polysaccharides:A review[J].Int J Biol Macromol,2021,183:119-131.
[22] LU C,LIU M,SHANG W,et al.Knowledge mapping of Angelica sinensis(Oliv.)Diels(Danggui)research:A scientometric study[J].Front Pharmacol,2020,11:294.
[23] LENG X,KAN H,WU Q,et al.Inhibitory effect of salvia miltiorrhiza extract and its active components on cervical intraepithelial neoplastic cells[J].Molecules,2022,27(5):1582.
[24] CAI T,WU W,GUO L,et al.Notoginsenoside R1 induces DNA damage via PHF6 protein to inhibit cervical carcinoma cell proliferation[J].Mol Med Rep,2021,23(4):242.
[25] 许鑫童,郭洁,宋殿荣,等.HR-HPV感染及宫颈病变的中医证候规律研究[J].天津中医药,2023,40(10):1248-1252.
[26] 刘艳梅,施桑桑,吴聪泉,等.HPV感染者的心理现状及相关影响因素研究[J].中国妇幼健康研究,2023,34(6):75-81.
[27] 徐冬冬,韩月欣,纪红玉.高危型人乳头瘤病毒感染者心理健康状况调查及影响因素分析[J].中国计划生育学杂志,2022,30(7):1491-1495.

备注/Memo

备注/Memo:
基金项目:国家中医药管理局第七批全国老中医药专家学术经验继承工作项目[国中医药人教函(2022)76号]; 北京市中医管理局文化课题(WHZX-2020-92); 北京中医药大学中央高校基本科研项目(2019-JYB-JS-166); 北京中医药大学第三附属医院科研孵化项目(2019kyfh-06); 北京中医药大学第三附属医院院级培育面上项目(BZYSY-2022-PYMS-13)
更新日期/Last Update: 2025-01-09